Company Profile
GeoVax Labs Stock Price, News & Analysis
- Ticker:
- GOVX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.72 USD (-2.78%)
Close
Last updated: August 6, 2026
10.9M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, GOVX closed down 2.78% at $0.7212. No new same-company headline was identified in the current news window.
Company overview
Business overview
GeoVax Labs is a biotechnology company developing vaccines and immunotherapies using a virus-like particle platform. Its story is built around infectious disease and oncology programs that seek to create targeted immune responses.
Geographic Base and Sector Classification
GeoVax is headquartered in the United States and listed on NASDAQ. It sits in small-cap vaccine and immunotherapy biotechnology.
Business Model Characteristics
The company depends on clinical and preclinical progress, partner interest, and capital efficiency to advance its platform. Investors watch vaccine updates, oncology programs, and whether the platform can produce differentiated immune responses.
Position Within the Biotechnology Landscape
GeoVax occupies a niche vaccine-and-immunotherapy position within biotech. It is a catalyst-driven small-cap name where platform validation matters more than commercial scale.
Future catalysts
GeoVax’s catalysts are vaccine and immunotherapy programs, plus any clinical or partnering step that keeps the platform relevant. The company still needs human proof.
Recent news
- 01
GeoVax Receives Notice of Allowance For Cancer Vaccine Patent
Source: GeoVax Labs
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of GeoVax Labs (GOVX)?
GeoVax Labs (GOVX) most recently closed at 0.72 USD, a -2.78% move versus the previous session.
What is the market cap of GeoVax Labs (GOVX)?
GeoVax Labs currently has a market capitalization of 10.9M USD on BioPharmSignal.
What does GeoVax Labs do?
GeoVax Labs is a biotechnology company developing vaccines and immunotherapies using a virus-like particle platform. Its story is built around infectious disease and oncology programs that seek to create targeted immune responses.
On which exchange is GOVX stock listed?
GeoVax Labs (GOVX) is associated with NASDAQ, United States, Biopharma.
What is GeoVax?
GeoVax’s catalysts are vaccine and immunotherapy programs, plus any clinical or partnering step that keeps the platform relevant.
Which conditions is GeoVax Labs targeting with GeoVax?
GeoVax Labs is associated with oncology based on its company overview and current catalyst commentary.
How does GeoVax Labs describe recent progress with GeoVax?
GeoVax’s catalysts are vaccine and immunotherapy programs, plus any clinical or partnering step that keeps the platform relevant.
What is Labs?
GeoVax Labs is a biotechnology company developing vaccines and immunotherapies using a virus-like particle platform.